Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 9—September 2020
Research

Retrospective Description of Pregnant Women Infected with Severe Acute Respiratory Syndrome Coronavirus 2, France

Alexandre J. VivantiComments to Author , Jérémie Mattern, Christelle Vauloup-Fellous, Jacques Jani, Luc Rigonnot, Larissa El Hachem, Agnès Le Gouez, Céline Desconclois, Imane Ben M’Barek, Jeanne Sibiude, Alexandra Benachi, Olivier Picone, and Anne-Gaël Cordier
Author affiliations: Antoine Béclère Hospital, Paris Saclay University, Clamart, France (A.J. Vivanti, J. Mattern, A. Le Gouez, C. Desconclois, A. Benachi); Paul Brousse Hospital, Paris Saclay University, Villejuif, France (C. Vauloup-Fellous); University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium (J. Jani); Centre Hospitalier Sud-Francilien, Corbeil-Essonnes, France (L. Rigonnot, L. El Hachem); Bicêtre Hospital, Paris Saclay University, Le Kremlin-Bicêtre, France (I. Ben M’Barek, A.-G. Cordier); Louis Mourier Hospital, Paris University, Colombes, France (J. Sibiude, O. Picone)

Main Article

Table 3

Laboratory parameters at diagnosis according to medical referral for pregnant women with severe acute respiratory syndrome 2 infection, France*

Laboratory findings Non-ICU hospitalization, n = 90
 ICU hospitalization, n = 10
 p value
Median (IQR) No. (%) Median (IQR) No. (%)
Hemoglobin, g/dL 11.4 (10.5–12.2) 64 (66.7) 9.8 (9.3–11.3) 9 (90) 0.02
Platelet count, × 109/L 230 (162–273) 63 (70.0) 205 (164–271) 9 (90) 0.98
Leukocyte count, × 109 cells/L
7.2 (5.4–8.9)
 63 (70.0)
6.6 (6.1–7.2)
 9 (90)
 0.68
Lymphocyte count, × 109 cells/L 1.15 (0.9–1.6) 58 (64.4) 0.77 (0.7–1) 9 (90) 0.01
Lymphocytopenia, <1.00 × 109 cells/L
 NA
 21/58 (36.2)†
NA
 8/9 (88.9)†
 0.008
Prothrombin time, % 100 (99–100) 53 (58.9) 100 (100–100) 7 (70) 0.61
aPPT, ratio 1.06 (1–1.2) 52 (57.8) 1.12 (1–1.4) 7 (70) 0.16
Prolonged aPPT ratio (>1.20) NA 13/53 (24.5)† NA 3/7 (43)† 0.38
Fibrinogen activity, g/L 4.8 (4–5.8) 45 (50.0) 5.1 (4.5–5.5) 6 (60) 0.73
AST, U/L 25 (20–35) 48 (53.3) 30 (22–59) 8 (80) 0.38
ALT, U/L 17 (11–32) 49 (54.4) 19 (12–48) 8 (80) 0.46
C-reactive protein, mg/L 23 (9–42) 53 (58.9) 27 (22–108) 8 (80) 0.15
Creatinine, μmol/L 47 (41–57) 45 (50.0) 50 (38–55) 7 (70) 0.94

*ALT, alanine aminotransferase; aPPT, activated partial thromboplastin time; AST, aspartate aminotransferase; ICU, intensive care unit; IQR, interquartile range; NA, not applicable.
†Per available results.

Main Article

Page created: July 02, 2020
Page updated: August 18, 2020
Page reviewed: August 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external